Inotuzumab ozogamicin as chemotherapy-sparing salvage in a 67-year-old man with primary refractory B-cell acute lymphoblastic leukemia with high-risk genomic features Journal Article


Authors: Yang, X.; Sen, F.; Geyer, M. B.
Article Title: Inotuzumab ozogamicin as chemotherapy-sparing salvage in a 67-year-old man with primary refractory B-cell acute lymphoblastic leukemia with high-risk genomic features
Abstract: Older adults with acute lymphoblastic leukemia (ALL) continue to have a poor prognosis, in part due to greater chemotherapy-related toxicities. We herein report a 67-year-old man with Philadelphia chromosome (Ph)-negative B-cell ALL, who exhibited refractoriness to 3 different regimens of induction chemotherapy and experienced multiple complications including intracranial bleeding and respiratory failure, who achieved minimal residual disease (MRD)-negative complete response (CR) after a single cycle of inotuzumab ozogamicin (IO). His ALL was characterized by several high-risk mutations, which may have contributed to chemotherapy-refractory disease. Our case supports incorporating IO into front-line induction regimens for older adults with high-risk B-cell ALL. © 2019
Keywords: clinical article; aged; primary tumor; gene mutation; case report; cancer risk; antineoplastic agent; cancer immunotherapy; acute lymphoblastic leukemia; high risk patient; cancer resistance; immunotherapy; genetic risk; brain hemorrhage; induction chemotherapy; respiratory failure; b cell leukemia; inotuzumab ozogamicin; philadelphia chromosome negative cell; older adults; human; male; priority journal; article
Journal Title: Leukemia Research Reports
Volume: 12
ISSN: 2213-0489
Publisher: Elsevier Inc.  
Date Published: 2019-01-01
Start Page: 100186
Language: English
DOI: 10.1016/j.lrr.2019.100186
PROVIDER: scopus
PMCID: PMC6904788
PUBMED: 31867204
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Mark Blaine Geyer
    83 Geyer
  2. Filiz   Sen
    26 Sen
  3. Xiaochuan Yang
    2 Yang